Hip fracture risk profiles in older Indigenous Australians
Authors: Michelle M Y Lai and Nicholas G Waldron
Published online: 1 August 2011
To the Editor: Although Indigenous males are twice as likely and Indigenous females are half as likely to report being diagnosed with osteoporosis compared with their non-Indigenous counterparts,1 data on the interracial differences in osteoporotic risk factors are limited.
Our study of 276 patients attending a tertiary hip fracture unit in Western Australia over a 5-year period is the first to report differences in common risk factors for hip fracture between Indigenous and non-Indigenous patients. Our data showed a lower likelihood of vitamin D deficiency and polypharmacy but higher likelihood of diabetes mellitus, renal disease and alcohol use among Indigenous patients with hip fracture compared with non-Indigenous patients.
Using the local orthogeriatric database, we identified 46 Indigenous and 230 randomly selected non-Indigenous patients aged ≥ 45 years who were transferred to a hip fracture unit following surgery for a minimal-trauma fracture at Royal Perth Hospital from July 2005 to June 2010. High alcohol use was defined as alcohol intake exceeding guideline recommendations,2 and polypharmacy as the use of more than five medications. We used a laboratory cut-off of 25-hydroxyvitamin D (25-OHD) < 50 nmol/L to indicate a low vitamin D level. Indigenous status was self-reported during admission.
We compared data for Indigenous and non-Indigenous patients using the Mann–Whitney U and Pearson χ2 tests. We used logistic regression (SPSS version 17; SPSS Inc, Chicago, Ill, USA) to examine the association between Indigenous status and the predictor variables.
Our study was exempted as a quality assurance activity from formal ethics review by the Royal Perth Hospital Ethics Review Committee and the Western Australian Aboriginal Health Information and Ethics Committee.
Risk factors among the two groups are shown in the Box. The most common risk factors among Indigenous patients were antihypertensive use, high alcohol use and diabetes. In the final multivariate model, Indigenous patients with hip fracture were significantly more likely to have diabetes and renal disease and to report high alcohol use, but significantly less likely to have a low vitamin D level and polypharmacy, after adjustment for age, sex and rural residency.
These well described risk factors contribute to fracture risk through two mechanisms: falls and secondary osteoporosis. Diabetes-related complications such as visual impairment, stroke and peripheral neuropathy can increase fracture risk.3 In renal dysfunction, osteoporosis is related to cortical thinning and uraemic osteodystrophy.4 Excessive alcohol intake at a young age among Indigenous people may affect peak bone mass.5 The effect of alcohol on liver cirrhosis, cognition, falls due to intoxication and peripheral neuropathy may contribute to fracture risk.
Risk stratification will be more robust if these results can be cross-validated in other institutions.
Associations between hip fracture and risk factors in Indigenous patients compared with non-Indigenous patients at Royal Perth hospital, July 2005 – June 2010
Variable |
Indigenous (n = 46) |
Non-Indigenous (n = 230) |
P* |
Crude OR |
Adjusted† OR (95% CI) |
||||||||||
Continuous (mean [SD]) |
|
|
|
|
|||||||||||
Age at hip fracture‡ (years) |
81.4 (9.1) |
82.3 (9.4) |
0.58 |
0.99 |
1.03 (0.96–1.10) |
||||||||||
25-OHD level (nmol/L) |
59.9 (30.2) |
40.9 (18.6) |
< 0.001 |
– |
– |
||||||||||
Categorical (no. [%]) |
|
|
|
|
|
||||||||||
Women |
29 (63%) |
161 (70%) |
0.35 |
1.11 |
2.52 (0.51–12.31) |
||||||||||
Non-metropolitan |
42 (93.3%) |
38 (16.6%) |
< 0.001 |
70.37 |
70.32 (14.43–342.59) |
||||||||||
Low vitamin D level§ |
15 (38.5%) |
142 (69.6%) |
< 0.001 |
0.27 |
0.26 (0.07–0.91) |
||||||||||
Prior fracture |
9 (19.6%) |
52 (22.6%) |
0.65 |
0.83 |
0.42 (0.09–1.90) |
||||||||||
High alcohol use¶ |
19 (41.3%) |
10 (4.3%) |
< 0.001 |
15.5 |
13.25 (1.89–92.92) |
||||||||||
Diabetes mellitus |
21 (45.7%) |
41 (17.8%) |
< 0.001 |
3.87 |
8.19 (2.02–33.18) |
||||||||||
Renal disease |
16 (34.8%) |
21 (9.1%) |
< 0.001 |
5.31 |
6.12 (1.29–29.05) |
||||||||||
Polypharmacy** |
18 (39.1%) |
137 (59.6%) |
0.01 |
0.44 |
0.17 (0.04–0.72) |
||||||||||
Antihypertensive use |
26 (56.5%) |
118 (51.3%) |
0.52 |
1.23 |
2.75 (0.70–10.76) |
||||||||||
25-OHD = 25-hydroxyvitamin D. OR = odds ratio. * Mann-Whitney U or Pearson χ2 test. Level of significance: P < 0.05. † Multivariate logistic regression. ‡ Minimal-trauma fracture. § 25-OHD level < 50 nmol/L. ¶ Alcohol intake exceeding guideline recommendations.2 ** > 5 drugs. |
|||||||||||||||
Acknowledgements
References
- Australian Institute of Health and Welfare. A snapshot of osteoporosis in Australia 2011. Canberra: AIHW, 2011. (AIHW Cat. No. PHE 137; Arthritis Series No.15.)
- National Health and Medical Research Council. Australian guidelines to reduce health risks from drinking alcohol. Canberra: Commonwealth of Australia, 2009. i1096034
- Janghorbani M, Feskanich D, Willett WC, Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care 2006; 29: 1573-1578. i1096036
- Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 2007; 39: 321-331. i1096038
- Malik P, Gasser RW, Kemmler G, et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 2009; 33: 375-381. i1096042
Costs of Delivering the Hep B PAST Model of Care in Remote Australia: A Retrospective Pre–Post Study
Hoa Nguyen, Anh Le Tuan Nguyen, Paula Binks, Melita McKinnon, Emily Vintour-Cesar, Karen Wills, Nicola Stephens, Benjamin Cowie, Joshua S. Davis, Yuejen Zhao, Peter Nihill, Julie A. Campbell, Andrew J. Palmer, Jane Davies, Barbara de Graaff
Epidemiology and Quality of Care for Aboriginal and Torres Strait Islander Peoples Treated by Emergency Medical Services for Stroke in Victoria, Australia: Retrospective Analysis of Linked Data
Candice Menezes, Ziad Nehme, Luke J. Burchill, Tegwyn McManamny, Angela Dos Santos, Michelle Crilly, Luke P. Dawson, Benjamin Clissold, David Anderson, Emily Nehme
Hepatitis C Among First Nations Australians: A Rethink Is Required to Meet the 2030 Elimination Target
James Ward, Emily Pegler, Kellie Stacy, Stephen Harfield
Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study
Alice R. T. Bergin, Luc te Marvelde, Roger L. Milne, Benjamin J. Solomon, Kris Ivanova, Peter Savas, Stephen J. Luen, Jay Hamann, Andrea Casey, Nicole Watt, Sue M. Evans, Gail Garvey, Sherene Loi
Rethinking Rheumatic Fever Diagnosis: Progress, Pitfalls and the Path Towards a Definitive Test
Anna P. Ralph, Rachel Webb, Tom Parks, Nicole J. Moreland, Asha C. Bowen, Benjamin Jones, Emma Ndagire, Andrea Z. Beaton
Not Gone but Often Forgotten: Action Needed to Address Tuberculosis in Aboriginal and Torres Strait Islander Communities
Nikkita Joshua, Emma L. Smith, Eunice (Cheeky) Love, Christopher P. Lowbridge, Nicole Tukana, Amy Bowden, Megan A. Campbell, Dawn Casey, James Ward